Skip to main content

Advertisement

Log in

Cardiac sympathetic dysautonomia in children with chronic kidney disease

  • Original Articles
  • Published:
Journal of Nuclear Cardiology Aims and scope

Abstract

Background

The pathophysiology of cardiovascular disease (CVD) in chronic kidney disease (CKD) remains uncertain, but autonomic dysfunction seems to be involved. The aim of the study is to investigate the cardiac dysautonomia in uremic pediatric individuals through iodine 123 metaiodobenzylguanidine (MIBG) scintigraphy and heart rate variability (HRV) analysis.

Methods and Results

We divided 40 CKD patients (aged 5–21 years) into 4 groups according to the treatment for CKD: conservative (n=7), continuous ambulatory peritoneal dialysis (n=5), hemodialysis (n=13), and kidney transplantation (n=15). Planar and tomographic I-123 MIBG images were acquired, and early and late cardiac uptake, cardiac and lung washout, and regional I-123 MIBG uptake were evaluated. Hemodialysis patients showed increased cardiac washout (P=.002), a heterogeneous pattern of I-123 MIBG distribution (P=.036), and lower values of the low-frequency (LF) component of HRV (P=.040). Subjects undergoing continuous ambulatory peritoneal dialysis had reduced lung washout (P=.030). The cardiac washout correlated positively with parathyroid hormone levels and negatively with creatinine clearance. There was a significant negative association between the LF component and cardiac washout.

Conclusions

Uremic cardiac dysautonomia may be characterized by a decreased LF component of HRV, increased I-123 MIBG washout, and a heterogeneous distribution pattern in the left ventricular walls; these abnormalities were not present after kidney transplantation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Sarnak MJ, Levey AS. Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis 2000;35(Suppl 1): S117–31.

    Article  Google Scholar 

  2. Kohlhagen J, Kelly J. Prevalence of vascular risk factors and vascular disease in predialysis chronic renal failure. Nephrology (Carlton) 2003;8:274–9.

    Article  Google Scholar 

  3. Frankel A, Brown E, Wingfield D. Management of chronic kidney disease. BMJ 2005;330:1039–40.

    Article  PubMed  Google Scholar 

  4. Kurata C, Wakabayashi Y, Shouda S, Okayama K, Yamamoto T, Ishikawa A, et al. Enhanced cardiac clearance of iodine-123-MIBG in chronic renal failure. J Nucl Med 1995;36:2037–43.

    PubMed  CAS  Google Scholar 

  5. Kurata C, Uehara A, Sugi T, Ishikawa A, Fujita K, Yonemura K, et al. Cardiac autonomic neuropathy in patients with chronic renal failure on hemodialysis. Nephron 2000;84:312–9.

    Article  PubMed  CAS  Google Scholar 

  6. Miyanaga H, Yoneyama S, Kamitani T, Kawasaki S, Takahashi T, Kunishige H. Abnormal myocardial uptake and clearance of 123I-labeled metaiodobenzylguanidine in patients with chronic renal failure and autonomic dysfunction. J Nucl Cardiol 1996;3(Pt 1): 508–15.

    Article  PubMed  CAS  Google Scholar 

  7. Kersh ES, Kronfield SJ, Unger A, Popper RW, Cantor S, Cohn K. Autonomic insufficiency in uremia as a cause of hemodialysis-induced hypotension. N Engl J Med 1974;290:650–3.

    PubMed  CAS  Google Scholar 

  8. Ewing DJ, Winney R. Autonomic function in patients with chronic renal failure on intermittent haemodialysis. Nephron 1975;15: 424–9.

    PubMed  CAS  Google Scholar 

  9. Campese VM, Kogosov E, Koss M. Renal afferent denervation prevents the progression of renal disease in the renal ablation model of chronic renal failure in the rat. Am J Kidney Dis 1995;26:861–5.

    Article  PubMed  CAS  Google Scholar 

  10. London GM, Fabiani F, Marchais SJ, De Vernejoul MC, Guerin AP, Safar ME, et al. Uremic cardiomyopathy: an inadequate left ventricular hypertrophy. Kidney Int 1987;31:973–80.

    Article  PubMed  CAS  Google Scholar 

  11. Converse RL Jr, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad-Tarazi F, et al. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 1992;327:1912–8.

    PubMed  Google Scholar 

  12. Cloarec-Blanchard L, Girard A, Houhou S, Grunfeld JP, Elghozi JL. Spectral analysis of short-term blood pressure and heart rate variability in uremic patients. Kidney Int Suppl 1992;37:S14–8.

    Google Scholar 

  13. Axelrod S, Lishner M, Oz O, Bernheim J, Ravid M. Spectral analysis of fluctuations in heart rate: an objective evaluation of autonomic nervous control in chronic renal failure. Nephron 1987;45:202–6.

    Article  PubMed  CAS  Google Scholar 

  14. Tory K, Sallay P, Toth-Heyn P, Szabo A, Szabo A, Tulassay T, et al. Signs of autonomic neuropathy in childhood uremia. Pediatr Nephrol 2001;16:25–8.

    Article  PubMed  CAS  Google Scholar 

  15. Miltenyi G, Tory K, Stubnya G, Toth-Heyn P, Vasarhelyi B, Sallay P, et al. Monitoring cardiovascular changes during hemodialysis in children. Pediatr Nephrol 2001;16:19–24.

    Article  PubMed  CAS  Google Scholar 

  16. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358–67.

    PubMed  CAS  Google Scholar 

  17. Crawford MH, Bernstein SJ, Deedwania PC, DiMarco JP, Ferrick KJ, Garson A Jr, et al. ACC/AHA Guidelines for Ambulatory Electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the Guidelines for Ambulatory Electrocardiography). Developed in collaboration with the North American Society for Pacing and Electrophysiology. J Am Coll Cardiol 1999;34:912–48.

    Article  PubMed  CAS  Google Scholar 

  18. DePuey EG, Port S, Wackers FJ, Rozanski A, Botvinick EH, Dae MW, et al. Nonperfusion applications in nuclear cardiology: report of a task force of the American Society of Nuclear Cardiology. J Nucl Cardiol 1998;5:218–31.

    Article  PubMed  CAS  Google Scholar 

  19. Morozumi T, Kusuoka H, Fukuchi K, Tani A, Uehara T, Matsuda S, et al. Myocardial iodine-123-metaiodobenzylguanidine images and autonomic nerve activity in normal subjects. J Nucl Med 1997;38:49–52.

    PubMed  CAS  Google Scholar 

  20. Kurata C, Shouda S, Mikami T, Wakabayashi Y, Nakano T, Sugiyama T, et al. Comparison of [123I]metaiodobenzylguanidine kinetics with heart rate variability and plasma norepinephrine level. J Nucl Cardiol 1997;4:515–23.

    Article  PubMed  CAS  Google Scholar 

  21. Kurata C, Uehara A, Ishikawa A. Improvement of cardiac sympathetic innervation by renal transplantation. J Nucl Med 2004;45: 1114–20.

    PubMed  Google Scholar 

  22. Patel AD, Iskandrian AE. MIBG imaging. J Nucl Cardiol 2002;9:75–94.

    Article  PubMed  Google Scholar 

  23. Dae MW, De Marco T, Botvinick EH, O'Connell JW, Hattner RS, Huberty JP, et al. Scintigraphic assessment of MIBG uptake in globally denervated human and canine hearts—implications for clinical studies. J Nucl Med 1992;33:1444–50.

    PubMed  CAS  Google Scholar 

  24. Tobes MC, Fig LM, Carey J, Geatti O, Sisson JC, Shapiro B. Alterations of iodine-131 MIBG biodistribution in an anephric patient: comparison to normal and impaired renal function. J Nucl Med 1989;30:1476–82.

    PubMed  CAS  Google Scholar 

  25. Johnson TS, Young JB, Landsberg L. Norepinephrine turnover in lung: effect of cold exposure and chronic hypoxia. J Appl Physiol 1981;51:614–20.

    PubMed  CAS  Google Scholar 

  26. Gillis CN, Pitt BR. The fate of circulating amines within the pulmonary circulation. Annu Rev Physiol 1982;44:269–81.

    Article  PubMed  CAS  Google Scholar 

  27. Lee YS. Ultrastructural observations of chronic uremic lungs with special reference to histochemical and X-ray microanalytic studies on altered alveolocapillary basement membranes. Am J Nephrol 1985;5:255–66.

    Article  PubMed  CAS  Google Scholar 

  28. Arao T, Takabatake N, Sata M, Abe S, Shibata Y, Honma T, et al. In vivo evidence of endothelial injury in chronic obstructive pulmonary disease by lung scintigraphic assessment of (123)I-metaiodobenzylguanidine. J Nucl Med 2003;44:1747–54.

    PubMed  Google Scholar 

  29. Simmons WW, Freeman MR, Grima EA, Hsia TW, Armstrong PW. Abnormalities of cardiac sympathetic function in pacing-induced heart failure as assessed by [123I]metaiodobenzylguanidine scintigraphy. Circulation 1994;89:2843–51.

    PubMed  CAS  Google Scholar 

  30. Gill JS, Hunter GJ, Gane G, Camm AJ. Heterogeneity of the human myocardial sympathetic innervation: in vivo demonstration by iodine 123-labeled meta-iodobenzylguanidine scintigraphy. Am Heart J 1993;126:390–8.

    Article  PubMed  CAS  Google Scholar 

  31. Vita G, Bellinghieri G, Trusso A, Costantino G, Santoro D, Monteleone F, et al. Uremic autonomic neuropathy studied by spectral analysis of heart rate. Kidney Int 1999;56:232–7.

    Article  PubMed  CAS  Google Scholar 

  32. Lombardi F, Malliani A, Pagani M, Cerutti S. Heart rate variability and its sympatho-vagal modulation. Cardiovasc Res 1996;32: 208–16.

    Article  PubMed  CAS  Google Scholar 

  33. Malliani A, Lombardi F, Pagani M. Power spectrum analysis of heart rate variability: a tool to explore neural regulatory mechanisms. Br Heart J 1994;71:1–2.

    Article  PubMed  CAS  Google Scholar 

  34. van de Borne P, Montano N, Pagani M, Oren R, Somers VK. Absence of low-frequency variability of sympathetic nerve activity in severe heart failure. Circulation 1997;95:1449–54.

    PubMed  Google Scholar 

  35. Zoccali C, Mallamaci F, Parlongo S, Cutrupi S, Benedetto FA, Tripepi G, et al. Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation 2002;105:1354–9.

    Article  PubMed  CAS  Google Scholar 

  36. Neumann J, Ligtenberg G, Klein II, Koomans HA, Blankestijn PJ. Sympathetic hyperactivity in chronic kidney disease: pathogenesis, clinical relevance, and treatment. Kidney Int 2004;65:1568–76.

    Article  PubMed  Google Scholar 

  37. Zoccali C, Mallamaci F, Tripepi G. Traditional and emerging cardiovascular risk factors in end-stage renal disease. Kidney Int Suppl 2003:S105–10.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Viviane Parisotto.

Additional information

This study was supported by grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnológico and Fundação de Amparo à Pesquisa do Estado de Minas Gerais.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Parisotto, V., Lima, E.M., Silva, J.M.P. et al. Cardiac sympathetic dysautonomia in children with chronic kidney disease. J Nucl Cardiol 15, 246–254 (2008). https://doi.org/10.1016/j.nuclcard.2008.01.003

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1016/j.nuclcard.2008.01.003

Key Words

Navigation